DeepMed Research

The Case Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1826-01-01

Employees: 5K

Market Cap: -

Website: http://www.case.edu/cancer

Clinical Trials

Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer

Early Phase 1

Withdrawn

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Pembrolizumab
Radiation: Stereotactic body radiotherapy

First Posted Date: 2018-06-29

Last Posted Date: 2020-04-07

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT03574220

Improved Intra-operative Safety From Optimal Selection of Anti-slip Surface

Not Applicable

Completed

Conditions: Vaginal Surgery
Laparoscopic Surgery

Interventions: Device: Bean Bag
Device: Pink Pad
Device: Gel Pad

First Posted Date: 2018-06-29

Last Posted Date: 2022-03-23

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 159

Registration Number: NCT03573557

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase 1

Active, not recruiting

Conditions: Glioblastoma

Interventions: Drug: Ibrutinib
Radiation: Radiation
Drug: Temozolomide (TMZ)

First Posted Date: 2018-05-24

Last Posted Date: 2025-01-08

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 36

Registration Number: NCT03535350

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC

Phase 1

Completed

Conditions: NSCLC
Non-small Cell Lung Cancer

Interventions: Drug: Osimertinib

First Posted Date: 2018-05-24

Last Posted Date: 2024-03-13

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT03535363

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Maimi Cancer Institute - Baptist Health South Florida, Miami, Florida, United States

Path2Quit Tobacco Intervention For African Americans

Not Applicable

Completed

Conditions: Smoking Cessation
Smoking, Tobacco

Interventions: Behavioral: Path2Quit
Behavioral: SmokeFreeText

First Posted Date: 2018-05-14

Last Posted Date: 2019-03-28

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 119

Registration Number: NCT03524482

Locations: 🇺🇸
Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Phase 1

Active, not recruiting

Conditions: Glioma
Glioblastoma

Interventions: Drug: ruxolitinib
Radiation: radiation
Drug: temozolomide

First Posted Date: 2018-05-02

Last Posted Date: 2025-01-08

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 60

Registration Number: NCT03514069

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation

Conditions: Percutaneous Tumor Ablation

Interventions: Device: HoloLens

First Posted Date: 2018-04-18

Last Posted Date: 2025-02-19

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 15

Registration Number: NCT03500757

Locations: 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Impact of Videos on Patient Anxiety and Satisfaction

Not Applicable

Withdrawn

Conditions: Mohs Surgery

Interventions: Behavioral: Pre-Operative Videos
Behavioral: verbal instructions
Behavioral: written instructions

First Posted Date: 2018-04-03

Last Posted Date: 2019-10-22

Lead Sponsor: Case Comprehensive Cancer Center

Registration Number: NCT03485937

Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma

Phase 1

Completed

Conditions: Basal Cell Carcinoma
Basal Cell Nevus Syndrome

Interventions: Drug: Dietary Vitamin D3 pre-treatment
Radiation: Photodynamic therapy
Drug: Serum Maintenance Vitamin D3

First Posted Date: 2018-03-16

Last Posted Date: 2024-10-17

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 37

Registration Number: NCT03467789

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Medical Dermatology Specialists Phoenix, Phoenix, Arizona, United States

3D Printed Models in Mohs Micrographic Surgery

Not Applicable

Completed

Conditions: Mohs Micrographic Surgery

Interventions: Behavioral: 3D printed model
Behavioral: Verbal Counselling

First Posted Date: 2018-03-12

Last Posted Date: 2021-05-21

Lead Sponsor: Case Comprehensive Cancer Center

Target Recruit Count: 82

Registration Number: NCT03461965

Locations: 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy